Lieberman; Paul M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lieberman; Paul M..The latest application filed is for "ebna1 inhibitors and methods using same".

Company Profile

8.9.11

Lieberman; Paul M. - Wynnewood PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
EBNA1 Inhibitors and Methods Using Same App 20220064112 - Messick; Troy E. ; et al.	2022-03-03
EBNA1 inhibitor crystalline forms, and methods of preparing and using same Grant 11,242,338 - Messick , et al. February 8, 2	2022-02-08
EBNA1 inhibitors and their method of use Grant 11,242,317 - Messick , et al. February 8, 2	2022-02-08
EBNA1 inhibitors and methods using same Grant 10,981,867 - Messick , et al. April 20, 2	2021-04-20
Ebna1 Inhibitors And Methods Using Same App 20200239415 - Messick; Troy E. ; et al.	2020-07-30
Ebna1 Inhibitors And Their Method Of Use App 20200181078 - Messick; Troy E. ; et al.	2020-06-11
EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Using Same App 20190352285 - MESSICK; TROY E. ; et al.	2019-11-21
EBNA1 inhibitors and methods using same Grant 10,442,763 - Messick , et al. Oc	2019-10-15
EBNA1 inhibitors and their method of use Grant 10,421,718 - Messick , et al. Sept	2019-09-24
Methods and Compositions for Re-activating Epstein-Barr Virus and Screening Compounds Therefor App 20190240202 - Lieberman; Paul M. ; et al.	2019-08-08
Methods and compositions for re-activating Epstein-Barr virus and screening compounds therefor Grant 10,307,406 - Lieberman , et al.	2019-06-04
Ebna1 Inhibitors And Methods Using Same App 20180305312 - Messick; Troy E. ; et al.	2018-10-25
Ebna1 Inhibitors And Their Method Of Use App 20180086699 - MESSICK; TROY E. ; et al.	2018-03-29
EBNA1 inhibitors and their method of use Grant 9,856,214 - Messick , et al. January 2, 2	2018-01-02
Ebna1 Inhibitors And Their Method Of Use App 20160289185 - MESSICK; TROY E. ; et al.	2016-10-06
Methods and Compositions for Re-activating Epstein-Barr Virus and Screening Compounds Therefor App 20160206601 - Lieberman; Paul M. ; et al.	2016-07-21
Compositions And Methods For Modulating The Activity Of Epstein-barr Nuclear Antigen 1 App 20160168144 - Lieberman; Paul M. ; et al.	2016-06-16
Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1 Grant 9,309,212 - Lieberman , et al. April 12, 2	2016-04-12
Compositions And Methods For Modulating The Activity Of Epstein-barr Nuclear Antigen 1 App 20140113897 - Lieberman; Paul M. ; et al.	2014-04-24

Company Registrations

NCAGE Code	46VK3	LIEBERMAN, PAUL M
CAGE Code	46VK3	LIEBERMAN, PAUL M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.